🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I/II , Open-label , Investigator-initiated Trail of Camreli...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2019-11-12
Trial ID
NCT04182724
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of camreli...
Status
Recruiting
Location
West China Hospital, Sichuan University
Start Date
2022-11-01
Trial ID
NCT05447702
Treatments Being Tested
This is a Phase Ib/II, open-label, multi-center umbrella study evaluating t...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2018-10-18
Trial ID
NCT03805399
Treatments Being Tested
To evaluate the clinical efficacy and safety of camrelizumab combined with ...
Status
Unknown
Location
The First Affiliated Hospital of Xiamen University
Start Date
2020-01-01
Trial ID
NCT04572542
Treatments Being Tested
This study aims to evaluate the efficacy and safety of the TPC regimen (nab...
Status
Recruiting
Location
SunYat-senU
Start Date
2024-05-30
Trial ID
NCT06438627
Treatments Being Tested
To evaluate the clinical efficacy and safety of camrelizumab combined with ...
Status
Completed
Location
Fujian Medical University Union Hospital
Start Date
2020-06-18
Trial ID
NCT04195828
Treatments Being Tested
To evaluate the clinical efficacy of camrelizumab, apatinib Mesylate and na...
Status
Not Yet Recruiting
Location
Fujian Medical University Union Hospital
Start Date
2022-09-01
Trial ID
NCT05524974
Treatments Being Tested
This randomized, open-label phase 3 study will evaluate the safety and effi...
Status
Terminated
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Start Date
2020-07-14
Trial ID
NCT04335006
Treatments Being Tested
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested